logo-loader
RNS
Primary Health Properties PLC

Primary Health Props - AGM Trading Update

RNS Number : 2815C
Primary Health Properties PLC
29 April 2026
 

29 April 2026

Primary Health Properties PLC

AGM Trading Update

Continued progress on delivery of strategic objectives and improving rental growth

Primary Health Properties PLC ("PHP", the "Group" or the "Company"), the UK's leading investor in critical healthcare infrastructure, today publishes a trading update for the first quarter of the year to 31 March 2026 ahead of its AGM later today.   

Mark Davies, CEO of PHP, commented:

"The first quarter of 2026 was a strong start to the year, with a continued focus on asset management and risk-controlled development, with organic rental growth from the enlarged portfolio's rent reviews delivering an extra £3 million of income, an increase of c.6% or 3.4% on an annualised basis (up from 3.2% in 2025).

"We have continued to make excellent progress on the delivery of the post Assura combination objectives, since we announced PHP's latest results in March. These include reducing leverage back to our target range of 40% to 50%, net debt/EBITDA below 9.5x, delivering £9 million of annualised cost synergies and integrating the two businesses, all of which we expect to complete ahead of schedule. We have made considerable progress in the period in establishing a new vehicle for our private hospital portfolio."

Improving rental growth

The Company continues to see an improving rental growth outlook, especially from rent reviews, with an extra £3 million of income generated in the quarter from 199 completed reviews. This represents a total increase of c.6% over the previous rent of £54 million, equivalent to 3.4% (2025: 3.2%) on an annualised basis. All parts of the enlarged portfolio are performing very well with Primary Care UK at +2.9%, Private Hospitals +3.7% and Ireland +4.4%.

We continue to see opportunities to drive more growth and efficiencies in the enlarged portfolio and the annualised contracted rent roll now stands at £345 million (2025: £342 million).

Establishment of a new strategic private hospital vehicle to reduce gearing

We have made considerable progress in establishing a new vehicle for our private hospital portfolio, and are on track with our previously reported plans to deliver a transaction that will reduce our gearing and act as an alternative source of capital and growth for the future. A shortlist of potential counterparties is engaged and the Board is focused on selecting a partner and structure that will deliver the optimum shareholder value for the future. We are confident that a transaction will be announced during the summer of 2026.

The transfer of a further £103 million of assets into our existing primary care joint venture continues to progress through legal due diligence and we expect this to complete on schedule before the end of July 2026.

Cost synergies

We continue to make good progress on the delivery of the £9 million cost saving target and have recently commenced a rationalisation programme aimed at rightsizing the enlarged Group. To date, £7.8 million of annualised cost saving synergies, or 87% of our target, have now been delivered.

Development pipeline and Neighbourhood Health Centres

The Department of Health and Social Care announced the first wave of Neighbourhood Health Centres ("NHC") at the end of March 2026. NHCs are intended to improve patient access, bringing additional health services closer to people's homes and provide a wider range of services in the community. The initial wave, of which three are existing PHP assets, provides investment in existing buildings to increase capacity, and we will work with the NHS to deliver these development and asset management opportunities. The full NHC programme targets delivery of 250 centres by 2035, and we continue to engage with the NHS and the Government on future opportunities.

PHP is currently on site with six development schemes; two UK primary care centres within the existing joint venture with USS, three schemes in Ireland and one private hospital. All schemes remain on track for completion during 2026 and 2027 and to deliver attractive returns.

We continue to monitor a number of potential development opportunities with a pipeline across primary care in both the UK and Ireland and private hospitals. These will only be progressed if accretive to earnings and they deliver the appropriate risk adjusted returns to shareholders.

Dividend

On 11 March 2026, the Company declared its second quarterly interim dividend of 1.825p per Ordinary Share which will be paid on 8 May 2026 to shareholders who were on the share register at the close of business on 27 March 2026. The dividend will be paid by way of a property income distribution of 1.325 pence and normal dividend of 0.5 pence. The dividend is equivalent to 7.3 pence on an annualised basis, representing a 2.8% increase over dividends paid in 2025, and marks the 30th year of consecutive dividend growth for PHP.

The Company intends to maintain its strategy of paying a progressive dividend, in equal quarterly instalments, covered by adjusted earnings in each financial year. Further dividend payments are planned to be made in August and November 2026 which are expected to comprise a mixture of both PID and normal dividend.

Annual General Meeting ("AGM")

The 2026 AGM of the Company is being held today, 29 April 2026, at the offices of CMS Cameron McKenna Nabarro Olswang LLP, Cannon Place, 78 Cannon Street, London EC4N 6AF at 10:30 a.m. (UK time) / 11.30 a.m. (South Africa time). At the meeting, shareholders will be able to engage with the Directors who will answer any questions and provide their thoughts on our performance and strategy. Further details of the AGM including the Notice of Annual General Meeting can be found on the Company's website www.phpgroup.co.uk.

 

- ENDS -

For further information contact:

Mark Davies

CEO

Primary Health Properties PLC

Richard Howell

CFO

Primary Health Properties PLC



David Purcell

Investor Relations

Primary Health Properties PLC

T: +44 (0) 7921 190 136

E: david.purcell@phpgroup.co.uk

 

Sodali & Co

Financial PR

Elly Williamson/Louisa Henry/Saskia Bottomley

T: +44 (0) 207 250 1446

E: PHP@client.sodali.com

 

 

 

Notes to editors

PHP is the UK's leading investor in modern healthcare infrastructure with a £6 billion portfolio invested in critical social assets across the UK and Ireland. The portfolio benefits from highly resilient operating metrics in a sector with strong fundamental demographic characteristics, supported by a positive political backdrop and the need for greater investment in healthcare infrastructure to support the delivery of services in local communities.

In 2025, PHP combined with Assura to create the UK's largest healthcare REIT placing the enlarged Group in the top quartile of the London Stock Exchange FTSE 250 index with the additional benefits of significantly increased share liquidity, investor reach and a lower cost of capital. PHP's unique portfolio, strong platform with a robust balance sheet and a disciplined focus rental growth and cost control supports our 30-year track record of paying an increased progressive dividend.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUQPCUPQGQR
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Director Announcement

1 week, 2 days ago

Director/PDMR Shareholding

2 weeks, 6 days ago

Director/PDMR Shareholding

3 weeks, 1 day ago

Director/PDMR Shareholding

3 weeks, 1 day ago

Director/PDMR Shareholding

3 weeks, 1 day ago

Director/PDMR Shareholding

3 weeks, 1 day ago

Director Dealings

3 weeks, 3 days ago

7 min read